CURA.CN

Record fiscal year 2022 revenue of $1.34 billion and Adjusted EBITDA(1) of $305 million, representing an increase of 12% and 17% from fiscal 2021, respectively Fourth quarter 2022 Revenue of $352.5 million, representing an increase of 14% year-over-year, and Adjusted EBITDA(1) of $73 million Operating cash flow of $46 million and cash on... Read More...

Third Quarter 2022 Revenue of $340 Million, an increase of 1% sequentially and 7% YoY Third Quarter 2022 Adjusted EBITDA(1) of $84 Million, an increase of 18% YoY Generated $60 Million of Positive Operating Cash Flow in the Third Quarter and $71 Million in the First Nine Months of 2022 WAKEFIELD, Mass., Nov. 7, 2022 -- Curaleaf Holdings,... Read More...

Second Quarter 2022 Revenue of $338 Million, an increase of 8% sequentially and YoY Second Quarter 2022 Adjusted EBITDA(1) of $86 Million, an increase of 18% sequentially and 2% YoY Generated $12 Million of Positive Operating Cash Flow for the First Half of 2022 WAKEFIELD, Mass., Aug. 8, 2022 -- Curaleaf Holdings, Inc. (CSE: CURA) (OTCQX... Read More...

First Quarter 2022 Revenue of $313 Million, up 20% YoY First Quarter 2022 Adjusted EBITDA(1) of $73 Million, up 16% YoY First Quarter 2022 Cash Flow from Operations of $57.4 Million or 18% of Revenue WAKEFIELD, Mass., May 9, 2022 -- Curaleaf Holdings, Inc. (CSE: CURA) (OTCQX: CURLF) ("Curaleaf"), a leading international provider of consu... Read More...